Cvs Health's Revenue in the fiscal year 2025 $ 402,067.00 millions
Cvs Health's Revenue in the fiscal year 2024 $ 372,809.00 millions
Cvs Health's Revenue in the fiscal year 2023 $ 357,776.00 millions
Cvs Health's Revenue in the fiscal year 2022 $ 322,467.00 millions
Cvs Health's Revenue in the fiscal year 2021 $ 292,111.00 millions
CVS Revenue second quarter 2026 Y/Y Growth Comment
Cvs Health Corporation reported Revenue growth of 7.26% year on year in the second quarter 2026, to $ 106,096.00 millions, this is lower than Cvs Health Corporation's recent average Revenue increase of 13.59%.
Looking into second quarter 2026 results within Pharmacy Services & Retail Drugstore industry 7 other companies have achieved higher Revenue growth. While Cvs Health Corporation' s Revenue increase of 7.26% ranks overall at the positon no. 2413 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Cvs Health's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
56.98 %
3.21 %
-8.5 %
(June 30. 2007)
CVS's II. Quarter Q/Q Revenue Comment
Cvs Health Corporation achieved in the II. Quarter 2026 above company average sequential Revenue increase of 5.65%, to $ 106,096.00 millions, from $100,426.00 millions in the first quarter. CVS is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Pharmacy Services & Retail Drugstore industry only one company achieved higher sequential Revenue growth. While Cvs Health's Revenue growth quarter on quarter, overall rank is 1107.
Cvs Health Corporation achieved in the II. Quarter 2026 above company average sequential Revenue increase of 5.65%, to $ 106,096.00 millions, from $100,426.00 millions in the first quarter. CVS is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Pharmacy Services & Retail Drugstore industry only one company achieved higher sequential Revenue growth. While Cvs Health's Revenue growth quarter on quarter, overall rank is 1107.
Cvs Health's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 415,086.00
$ 407,905.00
$ 402,067.00
$ 394,084.00
$ 386,641.00
Y / Y Revenue Growth (TTM)
7.36 %
7.64 %
7.85 %
6.82 %
6.44 %
Year on Year Revenue Growth Overall
Ranking
# 1905
# 716
# 586
# 174
# 1325
Seqeuential Revenue Change (TTM)
1.76 %
1.45 %
2.03 %
1.93 %
2.03 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2413
# 2397
# 1822
# 1625
# 2027
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Cvs Health's cumulative twelve months Revenue were $ 415,086 millions, company would post below average annual Revenue growth of 2.03% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Cvs Health's Revenue growth from the 100426% growth in Mar 31 2026.
In the Retail sector 57 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 716 to 1905.
With the quarterly Revenue reported in the Jun 30 2026 period, Cvs Health's cumulative twelve months Revenue were $ 415,086 millions, company would post below average annual Revenue growth of -2.35% year on year, if the fiscal year would end at Jun 30 2026. A slow-down in the Cvs Health's Revenue growth from the 100426% growth in Mar 31 2026.
In the Retail sector 57 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 716 to 1905.
About Cvs Health Revenue Growth Rates (CVS), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
12.55%